Ajanta Pharma Ltd. recalls Duloxetine Delayed-Release Capsules, 60 mg, Rx Only, 30 capsules, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 0
Recalled May 13, 2026 · FDA recall D-0515-2026 · Ajanta Pharma
Hazard
CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals. · FDA Class II
Units
77,376 packs.
Sold at
Nationwide within U.S
Description
CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.
Product
Duloxetine Delayed-Release Capsules, 60 mg, Rx Only, 30 capsules, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-099-03
Manufacturer(s)
Ajanta Pharma Ltd.
Made in
India
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →